Amoxicillin and Clavulanate Potassium for Oral recall: Subpotent
Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada…
Why was Amoxicillin and Clavulanate Potassium for Oral recalled?
Subpotent drug; Clavulanate Potassium component
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 100062316, Exp Date: 01/2026
- Product
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada…
- Recalling firm
- Teva Pharmaceuticals USA, Inc
- Quantity
- 4680 cartons
- Distribution
- Distributed in three (3) States: MS, OH, CA.
- Recall date
- November 12, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)